Skip to main content
CCCC logo

CCCC · C4 Therapeutics, Inc. · Share Buybacks

Track CCCC — free
$2.48 +0.04 (+1.64%) At close · Nov 20
Market Cap
$325.67M
Shares
131.32M
Volume · Nov 20 3.63M Avg daily vol (3M) 2.55M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$25,000,000
as of 2023-05-29

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2025-11 $125,000,000 — —
2024-10 $200,000,000 — —

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $239,000
2025-12-31 $193,000
2024-12-31 $194,000
2023-12-31 $110,000
2022-12-31 $0
2020-12-31 $194,000
2019-12-31 $30,000
Key facts CIK 1662579 CUSIP 12529R107 13F (30d) 159 filings 142 filers Visit website Investor relations